Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

Peer Review reports

Original Submission
13 Oct 2016	Submitted	Original manuscript
11 Nov 2016	Reviewed	Reviewer Report - Massimo Di Maio
14 Nov 2016	Reviewed	Reviewer Report - Stefania Scala
16 Jan 2017	Author responded	Author comments - Alison McDonnell
Resubmission - Version 2
16 Jan 2017	Submitted	Manuscript version 2
1 Feb 2017	Reviewed	Reviewer Report - Stefania Scala
10 Feb 2017	Reviewed	Reviewer Report - Massimo Di Maio
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
6 Jun 2017	Editorially accepted
15 Jun 2017	Article published	10.1186/s12885-017-3403-5

Back to article page